Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Drug Categories Experimental metabolic modulator, NNMT inhibitor, anti-obesity agent, muscle regenerative enhancer
based on readout pacing, I would project an NDA filing in late 2026 and a possible approval window in 2027 if results hold
These products are not medicines or drugs, have not been evaluated or approved by the U.S
While clinical interactions have not been documented, combining multiple compounds that affect similar pathways increases unpredictability
US$ 20.22
US$ 27.60
US$ 22.98
US$ 24.72
US$ 23.37
US$ 21.30
US$ 22.54
US$ 20.87
US$ 23.35
US$ 22.02
